In agreement with previous studies, we confirmed lower levels of circulating IGF-1 in participants with MetS and a decrease in IGF-1 levels associated with an increase in MetS criteria (Brugts et al. 2010; Oh et al. 2012; Parekh et al. 2010). The gene discussed is IGF1; the disease is metabolic syndrome.